Skip to content

Interventional trial with nutool therapy on patients of anxiety

A Study to evaluate the effectiveness of Nutool therapy (Irrigation) with Roghan-e-Kadu on patients of anxiety disorder attending South Delhi Hospital

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071695
Enrollment
60
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

Intervention1: Nutool therapy with Roghan-e-kadu: Duation of therapy- 30 minutes Total Sitting-11 follow up of alternate days for first 2 weeks followed by twice weekly for 2 weeks in test group Contr

Sponsors

Jamia Hamdard
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who fulfil the inclusion criteria of ICD-10 for Anxiety 2.Diagnosed and clinically stable patients of mild to moderate anxiety disorder by HAM-A scale 3.Willing to take Nutool therapy with Roghan-e-Kadu in experimental group 4.Willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with known psychiatric co-morbidity 2.Patients with dependent substance abuse 3.Pregnancy and lactation 4.Patients with known skin disorder 5.Major medical illness under treatment 6.Participation in another study or previous participation in similar study

Design outcomes

Primary

MeasureTime frame
HAM-A ScoreTimepoint: At baseline,4week,6week

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Aisha Perveen

Jamia Hamdard

aperveen@jamiahamdard.ac.in9818332134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026